| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 114.64M | 158.19M | 90.39M | 80.51M | 66.63M | 20.74M |
| Gross Profit | 18.48M | 27.89M | 23.34M | 20.08M | 16.25M | 5.71M |
| EBITDA | 687.00K | 384.00K | 5.87M | 5.61M | 5.90M | 804.93K |
| Net Income | -11.21M | -12.49M | -1.70M | -111.51K | 1.50M | 27.92K |
Balance Sheet | ||||||
| Total Assets | 54.09M | 73.72M | 56.71M | 57.09M | 39.13M | 8.72M |
| Cash, Cash Equivalents and Short-Term Investments | 678.00K | 1.50M | 1.15M | 5.12M | 2.68M | 1.23M |
| Total Debt | 45.20M | 49.85M | 27.27M | 22.84M | 12.30M | 2.73M |
| Total Liabilities | 58.89M | 69.64M | 40.27M | 38.62M | 21.81M | 4.85M |
| Stockholders Equity | -4.80M | 4.08M | 16.44M | 18.47M | 17.32M | 3.87M |
Cash Flow | ||||||
| Free Cash Flow | 7.79M | 3.02M | -3.20M | 3.38M | 24.13K | 479.20K |
| Operating Cash Flow | 10.38M | 5.93M | -1.27M | 4.04M | 1.97M | 804.89K |
| Investing Cash Flow | -4.00M | -26.43M | -3.33M | -12.67M | -16.08M | 894.94K |
| Financing Cash Flow | -6.24M | 20.85M | 625.00K | 11.07M | 15.56M | -424.55K |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
68 Neutral | C$1.38B | 16.68 | 65.09% | 3.16% | 8.68% | 39.93% | |
63 Neutral | C$252.96M | 1.98 | 39.85% | 2.45% | -40.05% | 558.77% | |
59 Neutral | C$1.75B | 47.54 | 6.94% | 4.94% | 10.13% | 1.30% | |
56 Neutral | C$229.69M | 3,650.00 | 0.11% | 0.56% | 0.19% | ― | |
55 Neutral | C$26.19M | 157.89 | 0.69% | ― | 11.89% | 5.56% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
42 Neutral | C$1.39M | -0.12 | -1473.72% | ― | -22.61% | 7.72% |
Premier Health of America Inc. reported its third-quarter results for 2025, highlighting a significant decline in revenue and adjusted EBITDA compared to the previous year, primarily due to reduced volumes in Quebec and British Columbia. The company’s net loss decreased, aided by favorable fair value adjustments and lower income tax. The implementation of Quebec’s Bill 10 continued to impact the Per Diem segment, which now accounts for only 4% of revenues. Despite challenges, the company is focusing on cost reduction, debt management, and operational efficiency, with plans to shift focus to Travel Nurses and explore opportunities in the Home Care sector.